Literature DB >> 10146942

Regulation of pharmaceutical prices: a managed care perspective.

R P Navarro.   

Abstract

Mesh：

Year:  1993        PMID： 10146942     DOI： 10.2165/00019053-199303030-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  1 in total

1.  Medicaid drug utilisation review under OBRA 1990: current issues and future directions.

Authors:  T R Fulda; S L Hass
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981
  1 in total
  3 in total

1.  Does managed care fuel pharmaceutical industry growth?

Authors:  M D Murray; F W Deardorff
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

2.  The effects of acquisition cost and budget-based compensation on the attitudes of pharmacy directors toward the adoption of a cost-effective new drug.

Authors:  M Kolassa; M C Smith; B F Banahan; D D Garner; W F Shughart
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

3.  Drug expenditures in a balanced strategy for healthcare policy.

Authors:  R J Bonk; M J Myers; W F McGhan
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.